ALLOVIR

allovir-logo

AlloVir focuses on the development of cell therapies and focuses on restoring natural immunity against the virus-associated diseases. It provides an ideal environment for ViraCyte to develop and advance its product pipeline from discovery through late-stage clinical trials. The company was founded in 2013 and headquartered in Houston, Texas.

#SimilarOrganizations #People #Financial #Event #Website #More

ALLOVIR

Social Links:

Industry:
Biotechnology Clinical Trials Pharmaceutical

Founded:
2013-01-01

Address:
Houston, Texas, United States

Country:
United States

Website Url:
http://www.allovir.com

Total Employee:
101+

Status:
Active

Contact:
(346)772-0319

Email Addresses:
[email protected]

Total Funding:
285.59 M USD

Technology used in webpage:
SPF Microsoft Exchange Online Amazon Office 365 Mail Google Maps GoDaddy DNS Google Maps API AWS Global Accelerator Google Maps For Work


Similar Organizations

advaxis-logo

Advaxis

Advaxis is a developer of multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer.

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focusesย on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

hookipa-pharma-logo

Hookipa Pharma

Hookipa is a clinical stage biotech company developing best-in-class active immunization therapies for infectious diseases and oncology.

navitor-pharmaceuticals-logo

Navitor Pharmaceuticals

Navitor Pharma is a developer of novel medicines designed to target specific nutrient-sensing proteins to treat diseases.

radius-health-logo

Radius Health

Radius Health develops drug therapies for osteoporosis and womenโ€™s health.

ultragenyx-pharmaceutical-logo

Ultragenyx Pharmaceutical

Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.


Current Advisors List

malcolm-brenner_image

Malcolm Brenner Board Of Directors @ AlloVir
Board_member

helen-heslop_image

Helen Heslop Board Of Directors @ AlloVir
Board_member

cliona-rooney_image

Cliona Rooney Board Of Directors @ AlloVir
Board_member

elizabeth-stoner_image

Elizabeth Stoner Senior Clinical Advisor @ AlloVir
Advisor
2017-10-01

Current Employees Featured

juan-vera_image

Juan Vera
Juan Vera Chief Product Development Officer @ AlloVir
Chief Product Development Officer

ann-leen_image

Ann Leen
Ann Leen Co-Founder & Chief Scientific Officer @ AlloVir
Co-Founder & Chief Scientific Officer
2013-01-01

diana-brainard_image

Diana Brainard
Diana Brainard Chief Executive Officer @ AlloVir
Chief Executive Officer
2021-05-01

edward-miller_image

Edward Miller
Edward Miller General Counse & Secretary @ AlloVir
General Counse & Secretary
2018-09-01

melissa-stundick_image

Melissa Stundick
Melissa Stundick Senior Vice President Business Development @ AlloVir
Senior Vice President Business Development
2022-03-01

dana-alexander_image

Dana Alexander
Dana Alexander SVP Technical Operations @ AlloVir
SVP Technical Operations
2020-09-01

vikas-sinha_image

Vikas Sinha
Vikas Sinha President & CFO @ AlloVir
President & CFO
2018-10-01

Founder


ann-leen_image

Ann Leen

cliona-rooney_image

Cliona Rooney

helen-heslop_image

Helen Heslop

john-wilson_image

John Wilson

juan-vera_image

Juan Vera

malcolm-brenner_image

Malcolm Brenner

Stock Details


Company's stock symbol is NASDAQ:ALVR

Investors List

ecor1-capital_image

EcoR1 Capital

EcoR1 Capital investment in Post-IPO Equity - AlloVir

invus_image

Invus

Invus investment in Post-IPO Equity - AlloVir

kite-pharma_image

Kite Pharma

Kite Pharma investment in Post-IPO Equity - AlloVir

gmt-capital_image

GMT Capital

GMT Capital investment in Post-IPO Equity - AlloVir

redmile-group_image

Redmile Group

Redmile Group investment in Post-IPO Equity - AlloVir

elevatebio_image

ElevateBio

ElevateBio investment in Post-IPO Equity - AlloVir

gilead-sciences_image

Gilead Sciences

Gilead Sciences investment in Post-IPO Equity - AlloVir

f2-ventures_image

F2 Ventures

F2 Ventures investment in Post-IPO Equity - AlloVir

fidelity-management-and-research-company_image

Fidelity Management and Research Company

Fidelity Management and Research Company investment in Series B - AlloVir

leerink-partners_image

Leerink Partners

Leerink Partners investment in Series B - AlloVir

Key Employee Changes

Date New article
2021-12-16 AlloVir Announces Departure of Chief Medical Officer Augustin Melian

Official Site Inspections

http://www.allovir.com Semrush global rank: 301.35 K Semrush visits lastest month: 211.43 K

  • Host name: a20b9ee60132ef283.awsglobalaccelerator.com
  • IP address: 13.248.155.104
  • Location: Seattle United States
  • Latitude: 47.6348
  • Longitude: -122.3451
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98109

Loading ...

More informations about "AlloVir" on Search Engine